TY  - JOUR
AU  - Novillo Villajos, Apolonia
AU  - Fernández-Santander, Ana
AU  - Gaibar, Maria
AU  - Galán, Miguel
AU  - Romero-Lorca, Alicia
AU  - El Abdellaoui-Soussi, Fadoua
AU  - Gómez-del Arco, Pablo
PY  - 2021
DO  - 10.3389/fonc.2021.633233
SN  - 2234-943X
UR  - https://hdl.handle.net/20.500.14352/130268
T2  - Frontiers in Oncology
AB  - Chromodomain-helicase-DNA-binding protein 4 (CHD4) is an epigenetic regulator identified as an oncogenic element that may provide a novel therapeutic target for the treatment of breast cancer (BC). CHD4-the core component of the nucleosome remodeling...
LA  - eng
M2  - 1
PB  - Frontiers
KW  - CHD4 gene
KW  - breast cancer
KW  - chromatin remodeling
KW  - mutation
KW  - therapies in breast cancer
TI  - Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer
TY  - journal article
VL  - 11
ER  -